GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.4630
-0.0025 (-0.54%)
At close: Sep 11, 2026, 4:00 PM EDT
0.4800
+0.0170 (3.67%)
After-hours: Sep 11, 2026, 7:55 PM EDT
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $3.41 million as of September 11, 2026. Its market cap has decreased by -80.47% in one year.
Market Cap
3.41M
Enterprise Value
591.68K
1-Year Change
-80.47%
Ranking
Category
Stock Price
$0.46
ChartMarket Cap Chart
Since September 11, 2019, GeoVax Labs's market cap has increased from $239.88K to $3.41M, an increase of 1,322.36%. That is a compound annual growth rate of 46.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 3.41M | -53.54% |
| Dec 31, 2025 | 7.34M | -68.49% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mustang Bio | 3.94M |
| Jupiter Neurosciences | 3.84M |
| PMGC Holdings | 3.72M |
| Addex Therapeutics | 3.59M |
| BioRestorative Therapies | 3.52M |
| Calidi Biotherapeutics | 3.40M |
| Silo Pharma | 3.34M |
| Aptevo Therapeutics | 3.30M |